Literature DB >> 11585719

BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression.

G C Sellar1, L Li, K P Watt, B D Nelkin, G J Rabiasz, E A Stronach, E P Miller, D J Porteous, J F Smyth, H Gabra.   

Abstract

The human homeobox BARX2 is located at 11q24-q25, within a minimal region associated with frequent loss of heterozygosity and adverse survival in epithelial ovarian cancer. BARX2 is a transcription factor that regulates transcription of specific cell adhesion molecules in the mouse. We show that BARX2 and cadherin 6 are expressed in normal human ovarian surface epithelium. BARX2 and cadherin 6 both have significantly lower expression in a clinical sample of endometrioid and clear cell ovarian cancers, as compared with serous or mixed mesodermal tumors. In a series of ovarian cancer cell lines, BARX2 expression showed a significant direct correlation with cadherin 6 expression. In OAW42, an ovarian cancer cell line that does not endogenously express BARX2, in vitro transfection of human BARX2 cDNA induced cadherin 6 expression. Transfection of BARX2 into OAW42 inhibited Matrigel invasion, haptotactic cellular migration to a collagen IV signal, and adhesion to collagen IV-coated plates. Our data demonstrate that BARX2 is expressed in the ovarian surface epithelium and has functional suppressor properties in ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585719

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration.

Authors:  Robyn Meech; Katie N Gonzalez; Marietta Barro; Anastasia Gromova; Lizhe Zhuang; Julie-Ann Hulin; Helen P Makarenkova
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  Barx2 and Fgf10 regulate ocular glands branching morphogenesis by controlling extracellular matrix remodeling.

Authors:  Cindy Tsau; Masataka Ito; Anastasia Gromova; Matthew P Hoffman; Robyn Meech; Helen P Makarenkova
Journal:  Development       Date:  2011-08       Impact factor: 6.868

3.  Is there a link between ovarian cancer and tooth agenesis?

Authors:  John Bonds; Sarah Pollan-White; Lilin Xiang; Gabriele Mues; Rena D'Souza
Journal:  Eur J Med Genet       Date:  2014-03-12       Impact factor: 2.708

4.  Characterization of HPV and host genome interactions in primary head and neck cancers.

Authors:  Michael Parfenov; Chandra Sekhar Pedamallu; Nils Gehlenborg; Samuel S Freeman; Ludmila Danilova; Christopher A Bristow; Semin Lee; Angela G Hadjipanayis; Elena V Ivanova; Matthew D Wilkerson; Alexei Protopopov; Lixing Yang; Sahil Seth; Xingzhi Song; Jiabin Tang; Xiaojia Ren; Jianhua Zhang; Angeliki Pantazi; Netty Santoso; Andrew W Xu; Harshad Mahadeshwar; David A Wheeler; Robert I Haddad; Joonil Jung; Akinyemi I Ojesina; Natalia Issaeva; Wendell G Yarbrough; D Neil Hayes; Jennifer R Grandis; Adel K El-Naggar; Matthew Meyerson; Peter J Park; Lynda Chin; J G Seidman; Peter S Hammerman; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 5.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

6.  Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.

Authors:  Jirong Long; Qiuyin Cai; Hyuna Sung; Jiajun Shi; Ben Zhang; Ji-Yeob Choi; Wanqing Wen; Ryan J Delahanty; Wei Lu; Yu-Tang Gao; Hongbing Shen; Sue K Park; Kexin Chen; Chen-Yang Shen; Zefang Ren; Christopher A Haiman; Keitaro Matsuo; Mi Kyung Kim; Ui Soon Khoo; Motoki Iwasaki; Ying Zheng; Yong-Bing Xiang; Kai Gu; Nathaniel Rothman; Wenjing Wang; Zhibin Hu; Yao Liu; Keun-Young Yoo; Dong-Young Noh; Bok-Ghee Han; Min Hyuk Lee; Hong Zheng; Lina Zhang; Pei-Ei Wu; Ya-Lan Shieh; Sum Yin Chan; Shenming Wang; Xiaoming Xie; Sung-Won Kim; Brian E Henderson; Loic Le Marchand; Hidemi Ito; Yoshio Kasuga; Sei-Hyun Ahn; Han Sung Kang; Kelvin Y K Chan; Hiroji Iwata; Shoichiro Tsugane; Chun Li; Xiao-Ou Shu; Dae-Hee Kang; Wei Zheng
Journal:  PLoS Genet       Date:  2012-02-23       Impact factor: 5.917

7.  Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis.

Authors:  Guodong Wang; Jian Liu; Yi Cai; Jie Chen; Wenbing Xie; Xiangqian Kong; Wenjie Huang; Hao Guo; Xiaodi Zhao; Yuanyuan Lu; Lu Niu; Xiaowei Li; Haijia Zhang; Chao Lei; Zhijie Lei; Jipeng Yin; Hao Hu; Fan Yu; Yongzhan Nie; Limin Xia; Kaichun Wu
Journal:  Oncotarget       Date:  2017-05-30

8.  HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

Authors:  Euan A Stronach; Albandri Alfraidi; Nona Rama; Christoph Datler; James B Studd; Roshan Agarwal; Tankut G Guney; Charlie Gourley; Bryan T Hennessy; Gordon B Mills; Antonello Mai; Robert Brown; Roberto Dina; Hani Gabra
Journal:  Cancer Res       Date:  2011-05-13       Impact factor: 12.701

9.  Immunohistochemical localization of barx2 in the developing fetal mouse submandibular glands.

Authors:  Takahiro Naka; Satoshi Yokose
Journal:  Acta Histochem Cytochem       Date:  2009-03-31       Impact factor: 1.938

10.  Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.

Authors:  Shu-Chun Lin; Shou-Yen Kao; Jennifer Chen-Yu Chang; Ying-Chieh Liu; En-Hao Yu; Ssu-Hsueh Tseng; Chung-Ji Liu; Kuo-Wei Chang
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.